Related references
Note: Only part of the references are listed.The role of kinin receptors in cancer and therapeutic opportunities
Patricia L. N. da Costa et al.
CANCER LETTERS (2014)
Contribution of Endogenous Bradykinin to Fibrinolysis, Inflammation, and Blood Product Transfusion Following Cardiac Surgery: A Randomized Clinical Trial
J. M. Balaguer et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Proteasome inhibition with bortezomib induces cell death in GBM stem-like cells and temozolomide-resistant glioma cell lines, but stimulates GBM stem-like cells' VEGF production and angiogenesis
Daniela A. Bota et al.
JOURNAL OF NEUROSURGERY (2013)
Icatibant, the bradykinin B2 receptor antagonist with target to the interconnected kinin systems
Delphine Charignon et al.
EXPERT OPINION ON PHARMACOTHERAPY (2012)
Kinin receptors as targets for cancer therapy
Carlos D. Figueroa et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
Current clinical development of PI3K pathway inhibitors in glioblastoma
Patrick Y. Wen et al.
NEURO-ONCOLOGY (2012)
Induction of Selective Blood-Tumor Barrier Permeability and Macromolecular Transport by a Biostable Kinin B1 Receptor Agonist in a Glioma Rat Model
Jerome Cote et al.
PLOS ONE (2012)
Unique biology of gliomas: challenges and opportunities
Stacey Watkins et al.
TRENDS IN NEUROSCIENCES (2012)
Bradykinin Promotes the Chemotactic Invasion of Primary Brain Tumors
Vedrana Montana et al.
JOURNAL OF NEUROSCIENCE (2011)
Bradykinin increases the secretion and expression of endothelin-1 through kinin B2 receptors in melanoma cells
Tsugunobu Andoh et al.
PEPTIDES (2010)
Stimulation of the bradykinin B1 receptor induces the proliferation of estrogen-sensitive breast cancer cells and activates the ERK1/2 signaling pathway
Luis Molina et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Bradykinin induces matrix metalloproteinase-9 expression and cell migration through a PKC-δ-dependent ERK/Elk-1 pathway in astrocytes
Hsi-Lung Hsieh et al.
GLIA (2008)
The activation of ERK1/2 MAP kinases in glioblastoma pathobiology and its relationship with EGFR amplification
Concha Lopez-Gines et al.
NEUROPATHOLOGY (2008)
Malignant gliomas in adults
Patrick Y. Wen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Bradykinin-induced microglial migration mediated by B1-bradykinin receptors depends on Ca2+ influx via reverse-mode activity of the Na+/Ca2+ exchanger
Masataka Ifuku et al.
JOURNAL OF NEUROSCIENCE (2007)
Epidemiology of brain tumors
James L. Fisher et al.
NEUROLOGIC CLINICS (2007)
Low dose of bradykinin selectively increases intracellular calcium in glioma cells
Yi-bao Wang et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition
S. Meloche et al.
ONCOGENE (2007)
Antagonist, partial agonist and antiproliferative actions of B-9870 (CU201) as a function of the expression and density of the bradykinin B1 and B2 receptors
G. Morissette et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O-6-methylguanine
W. P. Roos et al.
ONCOGENE (2007)
Non-peptide antagonists for kinin B1 receptors:: never insights into their therapeutic potential for the management of inflammation and pain
Maria M. Campos et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Phase II trial of intravenous lobradimil and carboplatin in childhood brain tumors: a report from the Children's Oncology Group
K. Warren et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Furan-2-ylmethylene thiazolidinediones as novel, potent, and selective inhibitors of phosphoinositide 3-kinase γ
Vincent Pomel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Modulation of mitogen-activated protein kinase cascades by differentiation-1 protein: Acquired drug resistance of hormone independent prostate cancer cells
JC Lin et al.
JOURNAL OF UROLOGY (2005)
Study of correlation between expression of bradykinin B2 receptor and pathological grade in human gliomas
YS Zhao et al.
BRITISH JOURNAL OF NEUROSURGERY (2005)
International union of pharmacology.: XLV.: Classification of the kinin receptor family:: from molecular mechanisms to pathophysiological consequences
LMF Leeb-Lundberg et al.
PHARMACOLOGICAL REVIEWS (2005)
Mitogenic signalling by B2 bradykinin receptor in epithelial breast cells
S Greco et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2004)
Enhancement of blood-tumor barrier permeability by Sar-[D-Phe8]des-Arg9BK, a metabolically resistant bradykinin B1 agonist, in a rat C6 glioma model
RC Cardoso et al.
BMC NEUROSCIENCE (2004)
Bradykinin receptor ligands: Therapeutic perspectives
F Marceau et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Involvement of the p38 mitogen-activated protein kinase cascade in hepatocellular carcinoma
K Iyoda et al.
CANCER (2003)
Facilitation of drug entry into the CNS via transient permeation of blood brain barrier: laboratory and preliminary clinical evidence from bradykinin receptor agonist, Cereport
CV Borlongan et al.
BRAIN RESEARCH BULLETIN (2003)
Share Paper
